• adjuvant therapies
• anti-inflammatoty and immuno-therapy
• antiandrogenic
• antiviral and associated therapy
• Amantadine
• ASC09/ritonavir
• azithromycin
• azvudine
• baloxavir marboxil
• bromhexine
• carrimycin
• chloroquine and derivatives
• chloroquine
• hydroxychloroquine
• zinc plus hydroxychloroquine
• danoprevir / ritonavir
• darunavir cobicistat
• darunavir/cobicistat plus chloroquine
• doxycycline
• Emtricitabine/tenofovir plus colchicine plus rosuvastatin
• Ensitrelvir (XOCOVA)
• favipiravir
• favipiravir plus interferon
• fluvoxamine
• hydroxychloroquine plus macrolides
• azithromycin plus hydroxychloroquine
• Interferon plus lopinavir/ritonavir
• ivermectin
• ivermectin plus doxycycline
• leronlimab
• lopinavir / ritonavir plus ribavirin
• lopinavir/ritonavir
• lopinavir/ritonavir plus chloroquine
• Lopinavir/ritonavir plus hydroxychloroquine
• lopinavir/ritonavir plus interferon ß-1a
• lopinavir/ritonavir, ribavirin and interferon beta-1b
• molnupiravir
• niclosamide
• nirmatrelvir / ritonavir (Paxlovid)
• nitazoxanide
• opaganib
• oseltamivir
• oseltamivir plus chloroquin
• remdesivir
• ribavirin
• ritonavir
• sofosbuvir
• sofosbuvir and daclatasvir
• sofosbuvir and ledipasvir
• tenofovir/emtricitabine
• tenofovir/emtricitabine plus hydroxychloroquine
• tranexamic acid
• tranilast
• triazavirin
• umifenovir (arbidol)
• zinc
• control
• Drugs for acid related disorders
• miscellaneous
• Oral antidiabetic drugs
• Renin-angiotensin-system-acting agents
• vaccines
• Vitamins

• COVID 19 hospitalized
• COVID 19 all comers
• COVID-19 mild to moderate
• COVID-19 severe or critically
• COVID 19 outpatients
• COVID-19 (hospitalized or not)
• COVID-19 prophylaxis (children)
• COVID-19 prophylaxis (excluding children)
• infections other than COVID-19
• Long COVID-19
• preventing respiratory virus transmission
• secondary prevention